- Research article
- Open Access
- Open Peer Review
St John’s wort use in Australian general practice patients with depressive symptoms: their characteristics and use of other health services
BMC Complementary and Alternative Medicine volume 14, Article number: 204 (2014)
While depression is frequently managed by general practitioners, often patients self-manage these symptoms with alternative therapies, including St John’s wort (SJW). We tested whether use of SJW was associated with different patterns of conventional and complementary health service use, strategies used for management of depression, or user dissatisfaction with or lack of trust in their general practitioner or clinic overall.
Secondary analysis of data collected from an Australian population screened for a longitudinal cohort study of depression. Main outcome measures were CES-D for depressive symptoms, satisfaction with their general practitioner (GPAQ), Trust in Physician scale, self-report of health services usage and strategies used to manage depression, stress or worries.
Response rate was 7667/17,780 (43.1%). Of these, 4.3% (320/7,432) had used SJW in the past 12 months (recent ‘SJW users’). SJW users were significantly more likely to be depressed and to have a higher CES-D score. There were no statistically significant differences between recent SJW users and non-SJW users in satisfaction with their general practice or in trust in their general practitioner (GP) when adjusted for multiple factors. SJW users were significantly more likely to use all health services, whether conventional or complementary, as well as other strategies used for mental health care. SJW users were also more likely to consider themselves the main carer for their depression.
Primary care attendees with symptoms of depression who use SJW appear not to be rejecting conventional medicine. Rather, they may be proactive care seekers who try both conventional and complementary strategies to manage their depressive symptoms. If GPs enquire and find that their depressed patients are using SJW, this may indicate that they might explore for unrelieved symptoms of depression and also consider the issue of potential for interactions between SJW and other medicines.
Depression is a condition commonly managed in general practice. Treatments available to people experiencing depression and other mental health problems include prescription medicines, over-the-counter treatments, care from medical and other practitioners, as well as self-initiated options . Many people with mental health issues do not seek formal care .
St John’s wort (SJW, botanical name Hypericum perforatum) has been used for centuries in the treatment of mental health disorders. SJW is a herbal medicine that doctors need to be aware of due to its popularity, evidence of its effectiveness in depression, and its potential for interactions with other medicines. SJW forms part of the standard care for depression in Germany  and has been found to be one of the more popular complementary and alternative medicines (CAM) used by consumers in the US . In an Australian community-based sample of three age cohorts (N = 7485), over the past month 5.6% had taken antidepressant medicines and 1.1% had used a complementary or alternative medicine (CAM) for depression and 2.4% for anxiety, of which, two-thirds (63%) had taken SJW .
Of all CAM, SJW has been the most tested in clinical trials . A Cochrane review found evidence to support the use of SJW for treatment of major depression . Although SJW has fewer side effects than conventional antidepressants, it has clinically important interactions with some conventional drugs, in particular, with selective serotonin reuptake inhibitors (SSRIs) . It is for this reason that the National Institute for Health and Care Excellence (NICE) clinical guidelines do not recommend its use in the United Kingdom.
Herbal medicines are regulated slightly differently in different countries, which may have an impact on its availability to consumers. SJW is regulated in the UK by the Medicines Healthcare products Regulatory Agency (MHRA). To sell a product containing SJW over-the-counter in the UK, companies must obtain either full Marketing Authorisation or Traditional Herbal Registration (THR). The former requires evidence of efficacy, but companies can choose to follow the route of THR which only requires evidence of traditional use, safety, and quality of the product. In Australia, SJW is regulated by the Therapeutic Goods Administration as a listed medicine, in a similar process to THR. SJW may be recommended to patients by their general practitioners  or by complementary therapists; however, SJW can also be purchased over-the-counter with no professional input, which is a concern due to its potential for interactions with other medicines.
Little research has addressed why consumers use SJW . An interview-based study conducted in the United States with 22 current users of SJW found four dominant decision-making themes: (1) participants (or their parents) had a history of CAM use and believed in personal control of their heath; (2) lowered mood; (3) self-diagnosis of “minor” depression, high risks of prescription drugs, and a perception of safety with herbal remedies, and (4) barriers to and lack of knowledge of conventional health care providers and awareness of the ease of use and popularity of SJW .
No research has explored how people who use SJW for depressive symptoms also use other treatments, whether conventional or complementary or alternative. We explored whether primary care attendees, who had used SJW to manage depressive symptoms in the last 12 months, were also more likely to use other strategies and components of the conventional and complementary health care systems to manage their depressive symptoms, and whether they differed from non-SJW users in their satisfaction with or trust in their general practitioner and their clinic overall. Our hypothesis was that recent use of SJW would not be associated with marked differences in health service use or in attitudes to general practice compared with people who had not used SJW.
We undertook a secondary cross sectional analysis of screening data from a large cohort study in general practice, which explores how patients deal with depression, stress or worries called the Diagnosis, Management and Outcomes of Depression in Primary Care (diamond) study conducted in Victoria, Australia. diamond is a prospective, longitudinal cohort study of general practice attendees with depression from 30 randomly selected metropolitan and rural general practices, that began in January 2005. Clinic records were searched to identify all people aged 18-75 years who had seen the study GP in the previous year. Each GP examined this list and excluded those people who could not read English, were terminally ill, or resided in a nursing home. Between January and December 2005, random samples of about 600 eligible people from each general practice were mailed a screening survey with a covering letter from the GP and one follow up reminder letter after two weeks.
In addition to this initial survey, we report some results from a baseline telephone interview, conducted on average four weeks after the survey, between January 2005 and April 2006, with participants who met defined diagnostic criteria for depression. The study received Human Research Ethics Committee Approval from The University of Melbourne and full details of the methods have been reported .
Of the 17,780 people initially sent a screening survey as part of the diamond study, 7,667 (43%) returned a completed survey. The mean age of people who were sent the screening survey was 46.2 years (SD 15.3) and 60.7% were women. People who returned the survey were on average older (50.9 years; SD 14.2) and more likely to be female (66.5%).
Of these respondents, 97% (N = 7,432) answered a question on whether they had used St John’s wort for depression, stress or worries during the past 12 months and thus form our sample and the comparison groups for this study (recent SJW users and non-SJW users). The 12 month timeframe was chosen to allow a comparison with use of health care services, self-initiated strategies used for depression, stress or worries, and other scales which measure outcomes over the same timeframe.
In addition to the Centre for Epidemiologic Studies Depression Scale (CES-D) used to identify depressive symptoms for both the screening and outcome measures , the screening process included questions about the following topics and used the following validated scales:
Use of health care practitioners
Participants were asked whether in the past 12 months they had seen any traditional health professionals (hospital doctor, specialist doctor, physiotherapist, psychologist, counsellor, psychiatrist, nurse, social worker, alcohol or drug worker or family therapist) or complementary therapists (chiropractor, naturopath, homeopath, acupuncturist or other natural therapist).
Strategies tried for depression, stress or worries
Participants were also asked to indicate strategies they had tried for depression, stress or worries in the past 12 months by ticking items in a comprehensive list. The list included the following activities: exercise, yoga, counselling, hypnosis, depression medication, sleeping medication, acupuncture, relaxation or meditation, massage or touch therapy, aromatherapy, changed diet, reduced use of alcohol or illicit drugs, attended self-help group for emotional wellbeing or alcohol or drug withdrawal, read a self-help book, prayer, educational or therapeutic websites, telephone helpline and talked to family or friends.
Satisfaction with general practice
The General Practice Assessment Questionnaire (Version 1.0; GPAQ) measures satisfaction with receptionists; access to practice; continuity of care; communication; practice nurses; and practice overall. The GPAQ has been validated in the UK, but also has been tested in this Australian cohort .
The Trust in Physician scale  is an eleven-item instrument presented in a five-point Likert format. The original scale was further validated and modified to make it appropriate for the primary care setting: one item, ‘My doctor is a real expert in taking care of medical problems like mine’ was modified to read ‘My doctor is well qualified to manage (diagnose and treat or make an appropriate referral) medical problems like mine’. The response labels were changed from (1 = strongly disagree; 3 = uncertain; 5 = strongly agree) to (1 = totally disagree; 3 = neutral; 5 = totally agree). The last version of the instrument was used in the diamond study. .
Finally, those participants who screened positive for depressive symptoms (≥16 on the CES-D) and entered the diamond cohort were asked at study baseline in a computer assisted telephone interview: ‘At present, who do you consider is the main person caring for your depression?’
Data were analysed using STATA version 11  and summarised using frequencies and percentages for categorical data, and means and standard deviations (SD) for continuous data.
Participants were divided into two groups according to whether or not they reported taking SJW in the past 12 months. Logistic regression was used to examine the demographic characteristics of SJW users and to investigate the association between SJW usage and 1) health service use; 2) other strategies used for mental health care; 3) depression scores measured by CES-D; and 4) in the subgroup who screened positive for depression, whether SJW users consider themselves the main carer for their depression. Generalised estimating equations with robust standard errors were used to allow for the clustering effect, i.e. the correlation of individual responses from the same general practice.
Mixed effects linear regression models (treating the GP practice as a random effect and patient characteristics as fixed effects) were used to calculate differences in means and 95% confidence intervals (CI) for GPAQ and Trust in Physician scores. Satisfaction with nursing care was reported only for participants from clinics with a practice nurse.
A logistic regression model, used to analyse health service use and other strategies, controlled for participant characteristics including age, sex, general practice location as well as general health rating and whether they scored positively (≥16) for depressive symptoms on CES-D. These participant characteristics were chosen because of their association with patient ratings of GPs . In terms of general practice location, participants were classified into Socio-Economic Indexes for Areas (SEIFA) deciles on the Index of Relative Socio-economic Disadvantage (IRSD) and Index of Relative Socio-economic Advantage and Disadvantage (IRSAD). The IRSAD provides a continuum score (or decile) of advantage (high values) to disadvantage (low values). The IRSD only measures relative disadvantage, so a high score (or decile) reflects a relative lack of disadvantage rather than relative advantage. Cut-off points of 8 in IRSD and 9 in IRSAD were created based on grouping contiguous values of SEIFA deciles in the sample into two halves, where the first half was associated with lower scores and the second half with higher scores .
The mixed effects linear regression models investigating associations between satisfaction, trust and various aspects of their general practice were additionally controlled for number of visits to the participant’s usual GP, and the number of GPs seen in the previous year.
The association between SJW use and caring for own depression was undertaken with logistic regression using generalised estimating equations with robust standard errors. Regression was controlled for the effects of age, sex, general practice location and additionally for depression measured by Patient Health Questionnaire (PHQ) .
Results are reported as unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals [CI] and p values (p). Due to the number of analyses conducted, statistical significance was set at p < 0.01.
Results and discussion
Of 7667 participants, 1793 (23.4%) screened positive for a probable diagnosis of depression on the CES-D (> = 16). Of participants responding to the diamon d screening survey question on SJW use, a total of 4.3% (320/7432; 95% CI 3.8%, 4.8%) reported using SJW in the past 12 months, compared with 18.2% (1351/7432, 95% CI 17.3%, 19.1%) who used antidepressants. The demographic characteristics of participants are shown in Table 1. SJW users were more likely to be younger, female, single, have completed higher education, employed, to have been told by their doctor that they have depression or anxiety, taking medications for depression and to see a female GP.
SJW use was associated with a diagnosis of probable depression as rated by CES-D score of 16 or more (CES-D > =16: 43.8% SJW users; 23.5% non-SJW users; OR 2.44, 95% CI 1.99, 3.00, p < 0.001). We separated participants according to two recommended cut-off scores ≥16 (indicating probable depression) and ≥ 20 (indicating a significant elevation in depressive symptomatology in primary care sample). [19, 20] See Table 2.
We explored how this sample used both conventional and complementary health practitioners. After adjustment for self-rated health status, SJW users were significantly more likely to see their GP five or more times in the past year (51.3%, 43.3%), although this became non-significant when further adjusted for depression score. SJW users were significantly more likely to use all other health services, whether conventional or complementary (see Table 3).
When examining self-initiated strategies used for depression, stress or worries, SJW users were significantly more likely to have tried all listed strategies (see Table 4). For example, SJW users were more likely to have tried counsellors [adjusted Odds Ratio (adj OR) 3.45, 95% CI 2.38, 5.01] and sleeping tablets (adj OR 2.46, 95% 1.73, 3.52), but also acupuncture (adj OR 6.00, 95% CI 3.71, 9.69), hypnosis (adj OR 5.31, 95% CI 2.90, 9.74) or aromatherapy (adj OR 4.30, 95% CI 3.26, 5.67).
Table 5 shows no statistically significant differences in participants’ satisfaction with various aspects of their general practice or in their trust in their GP when adjusted for age, gender, general practice location, health rating, number of general practice visits, number of general practitioners seen and for depression score.
Finally, those participants who fulfilled diagnostic criteria for depression on the CES-D scale were asked in a computer assisted telephone interview (CATI) (n = 717; from those there were 5 missing responses related to usage of SJW) who they considered was the main person caring for their depression (if the participant did not identify with the term ‘depression’, the interviewer then used the phrase ‘or the way you are feeling’). The association between SJW use and caring for own depression was investigated using logistic regression controlled for the effects of age, sex, general practice location and additionally for depression measured by Patient Health Questionnaire (PHQ) . Half (50%; n = 32) of SJW users considered that they themselves were the main person caring for their depression, compared to 33.8% (n = 219) of non-SJW users. SJW users were more likely to consider themselves as the main person caring for their depression, and this association was significant (OR = 1.97; 95% CI 1.02, 3.83; p < 0.05). In contrast, only 9% of SJW users thought that a GP was the main person caring for their depression, compared to 16% of non-SJW users.
Summary of main findings
Our research has three main findings. Importantly in this large randomly selected general practice population, we found that recent SJW users were no different from non-SJW users in their satisfaction with various aspects of their general practice experience or in their trust in their GP. However, SJW users were significantly more likely to use all health services in general and to use a wide range of strategies for their depression, both conventional and complementary. Of participants currently depressed, SJW users were more likely to consider themselves the main carer for their depression, while non-SJW users were more likely to consider their GP to be the main person caring for their depression. These findings may indicate that patients who consult general practitioners and who have experienced symptoms of depression do not use SJW due to dissatisfaction with or lack of trust in their general practitioner or their clinic; rather, it may be that some aspects of their depression symptoms persist and may be more severe or less responsive to convention therapies and these participants sought additional help. We did not ask participants who it was that recommended that they try SJW, so it is possible that it was a recommendation of their GP. Regardless, patients who had recently used SJW are possibly a group more proactive in seeking care.
Comparison with existing literature
In the diamond screening survey, nearly 25% of respondents met the CES-D criteria for probable depression and 18% had taken antidepressant medication in the past year. Although this is considerably higher than figures obtained by the population-based figures cited by the Australian Bureau of Statistics, who found that 9.7% of the population reported having an affective disorder , it is in keeping with other surveys conducted in the general practice setting .
Use of CAM in people with depression is common in the community. A national Finnish study found that 43% of people with ‘pure’ depression had used some type of CAM in the past 12 months, nearly always as a ‘complement’ to mainstream care . We found that the use of one particular CAM, SJW, appears to be a marker of active searching for relief in people experiencing depression, not as a marker of a philosophical orientation to CAM. It is not possible from our research to explore why this is so, but this finding is supported by previous research about complementary therapies in depression  and generally; for example, a recent Dutch study found that many people sought complementary therapists to obtain advice from a different viewpoint, while less than 20% had concerns about their mainstream care .
SJW users in general practice may prefer to seek care for their depressive symptoms from a range of sources or they may prefer to take responsibility for their care – the patient as a consumer . Some people prefer to avoid contact with a GP altogether . Alternatively, they may seek a range of strategies as they are not obtaining the relief they need from treatment being provided by their GP, which may relate to many factors, such as concern about harm associated with pharmaceutical antidepressants, lack of response to antidepressants or more severe depression . Qualitative research is needed to explore these possibilities.
The meaning of the question ‘who do you consider the main person caring for your depression’ is open to interpretation: it could refer to provision of therapies, to day-to-day care or to taking responsibility for choosing what kinds of therapies to use. Each of these interpretations invites a different type of response. However, it does seem that SJW users assume more personal responsibility for their depression care than non-SJW users.
Strengths and limitations of the study
The strengths of this research include the use of a large randomly selected general practice-based sampling frame, use of validated measures of depression, satisfaction and trust, and exploration of the use of a wide range self-initiated strategies for depression, stress or worries by general practice attendees.
The limitations include a relatively low response rate and that the survey was undertaken in only one Australian state, both of which could limit generalisability, reliance on self-report and the potential for recall bias, given that participants were requested to recall information over the past 12 months. It is unlikely that recall bias would affect differentially recall about the various therapies used and therefore it should not have a major impact on the results. It is not possible to determine from this research whether use of SJW or other complementary therapies was recommended by a GP or not. The data were collected in 2005/2006; however, while this may be viewed as a limitation, popularity of complementary medicines has not diminished over this time , so the findings of this research remain relevant.
Implications for future research or clinical practice
SJW use may be a marker of people searching for relief from depression and who are willing to try multiple self-help and professional treatments to deal with their problems. These people were also more likely to be users of other medicines in the past year such as antidepressants and sleeping tablets. While we cannot ascertain whether this indicates concurrent use, it certainly raises the issue of possible interactions with SJW. Authorities responsible for medicines regulation and education need to be aware of such use and put into place mechanisms to ensure that SJW users have access to information that addresses the potential risks of concurrent use.
In clinical practice, GPs should enquire about all CAM use in their patients, including SJW use, as CAM products may cause interactions or side-effects. Additionally in patients using SJW, GPs may need to enquire further about unrelieved symptoms of depression and other strategies their patients have tried; better communication about these issues may improve the doctor-patient relationship, and ultimately improve safe management of depression.
MP - MS BS, M Med, FRACGP, DRANZCOG, PhD.
KD - MaSocSci, MaSci(Stat), PGDipPhil&EthStud, PGDipRelStud.
KF - BA(Hons), PgDipLaw, PgDipLegalPractice.
MC - BA, PhD.
JG - MS BS, FRACGP, DRANZCOG, PhD.
Centre for Epidemiologic Studies Depression Scale
Complementary and alternative medicine
Computer assisted telephone interview
- Version 1.0 GPAQ:
General practice assessment questionnaire
Index of relative socio-economic advantage and disadvantage
Index of relative socio-economic disadvantage
Medicines Healthcare products Regulatory Agency
Patient health questionnaire
Socio-economic indexes for areas
St John’s wort
Traditional herbal registration
Olesen S, Butterworth P, Leach L: Prevalence of self-management versus formal service use for common mental disorders in Australia: findings from the 2007 National Survey of Mental Health and Wellbeing. Aust N Z J Psychiatry. 2010, 44: 823-830.
Linden M, Wurzendorf K, Ploch M, Schaefer M: Self medication with St. John's wort in depressive disorders: An observational study in community pharmacies. J Affect Disord. 2008, 107 (1-3): 205-210. 10.1016/j.jad.2007.07.019.
Braun L, Cohen M: Herbs and Natural Supplements: An Evidence-Based Guide. 2007, Sydney, Australia: Elsevier, 2
Kennedy J: Herb and supplement use in the US adult population. Clin Ther. 2005, 27 (11): 1847-1858. 10.1016/j.clinthera.2005.11.004.
Parslow R, Jorm A: Use of prescription medications and complementary and alternative medicines to treat depressive and anxiety symptoms: results from a community sample. J Affect Disord. 2004, 82 (1): 77-84. 10.1016/j.jad.2003.09.013.
Werneke U, Turner T, Priebe S: Complementary medicines in psychiatry: review of effectiveness and safety British. Br J Psychiatr. 2006, 188: 109-121. 10.1192/bjp.188.2.109. doi:10.1192/bjp.188.2.109
Linde K, Berner M, Kriston L: St John's wort for major depression. Cochrane Database Syst Rev. 2008, CD000448-doi:000410.001002/14651858.CD14000448.pub14651853, 4
McGarry H, Pirotta M, Hegarty K, Gunn J: General practitioners and St. John’s Wort: a question of regulation or knowledge?. Complement Ther Med. 2007, 15: 142-148. 10.1016/j.ctim.2006.02.002.
Wagner P, Jester D, LeClair B, Taylor A, Woodward L, Lambert J: Taking the edge off: why patients choose St. John's Wort. J Fam Med. 1999, 48 (8): 615-619.
Gunn J, Gilchrist G, Chondros P, Ramp M, Hegarty K, Blashki G, Pond D, Kyrios M, Herrman H: Who is identified when screening for depression is undertaken in general practice? Baseline findings from the diagnosis, management and outcomes of depression in primary care (diamond) longitudinal study. Med J Aust. 2008, 188 (12): S119-S125.
Radloff L: The Center for Epidemiologic Studies Depression Scale. A self report depression scale for research in the general population. Applied Psychological Measurement. 1977, 1 (3): 385-401. 10.1177/014662167700100306. doi: 310.1177/014662167700100306
Potiriadis M, Chondros P, Gilchrist G, Hegarty K, Blashki G, Gunn J: How do Australian patients rate their general practitioner? A descriptive study using the General Practice Assessment Questionnaire. Med J Aust. 2008, 189: 215-219.
Anderson L, Dedrick R: Development of the Trust in Physician scale: a measure to assess interpersonal trust in patient-physician relationships. Psychol Rep. 1990, 67 (3 Pt 2): 1091-1100.
Thom DH, Ribisl KM, Stewart AL, Luke DA, Physicians TSTS: Further validation and reliability testing of the Trust in Physician Scale. Med Care. 1999, 37 (5): 510-517. 10.1097/00005650-199905000-00010.
StataCorp: Stata Statistical Software, Release 11. College Station. 2009, Texas: StataCorp LP
Campbell J, Ramsay J, Green J: Age, gender, socioeconomic, and ethnic differences in patients’ assessments of primary health care. Qual Health Care. 2001, 10: 90-95. 10.1136/qhc.10.2.90.
Australian Bureau of Statistics: Australian Social Trends, 2008 - Complementary Therapies. 2008, Canberra: Australian Bureau of Statistics
Spitzer R, Kroenke K, Williams JB: Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA. 1999, 282 (18): 1737-1744. 10.1001/jama.282.18.1737.
Herrman H, Patrick DL, Diehr P, Martin ML, Fleck M, Simon GE, Buesching DP, Group TL: Longitudinal investigation of depression outcomes in primary care in six countries: the LIDO Study. Functional status, health servicesuse and treatment of people with depressive symptoms. Psychol Med. 2002, 32 (5): 889-902.
Lyness JM, Noel TK, Cox C, King DA, Conwell Y, Caine ED: Screening for depression in elderly primary care patients: a comparison of the Center for Epidemiologic Studies - Depression Scale and the Geriatric Depression Scale. Archives of Internal Medicine. 1997, 157 (4): 449-454. 10.1001/archinte.1997.00440250107012.
Australian Bureau of Statistics: 4338.0 - Profiles of Health, Australia, 2011-13. 2013, Canberra: Australian Bureau of Statistics
Gilchrist G, Gunn J: Observational studies of depression in primary care: what do we know?. BMC Fam Pract. 2007, 8: 28-10.1186/1471-2296-8-28.
Wahlstrom M, Sihvo S, Haukkala A, Kiviruusu O, Pirkola S, Isometso E: Use of mental health services and complementary and alternative medicine in persons with common mental disorders. Acta Psychiatr Scand. 2008, 118 (1): 73-80. 10.1111/j.1600-0447.2008.01192.x.
van Dulmen S, de Groot J, Koster D, Heiligers P: Why Seek Complementary Medicine? An Observational Study in Homeopathic, Acupunctural, Naturopathic and Mainstream Medical Practice. J Complementary and Integrative Medicine. 2010, 7 (1): Article 20-doi:10.2202/1553-3840.1275
Baarts C, Pedersen I: Derivative benefits: exploring the body through complementary and alternative medicine. Sociol Health Illn. 2009, 31 (5): 719-733. 10.1111/j.1467-9566.2009.01163.x. doi:710.1111/j.1467-9566.2009.01163.x
Badger F, Nolan P: Use of self-chosen therapies by depressed people in primary care. J Clin Nurs. 2007, 16 (7): 1343-1352. 10.1111/j.1365-2702.2007.01769.x.
Jorm A, Korten A, Rodgers B, Pollitt P, Jacomb P, Christensen H, Jiao Z: Belief systems of the general public concerning the appropriate treatments for mental disorders. Social Psychiatry and Psychiatric Epidemiology. 1997, 32 (8): 468-473.
Hunt KJ, Coelho HF, Wider B, Perry R, Hung SK, Terry R, Ernst E: Complementary and alternative medicine use in England: results from a national survey. Int J Clin Pract. 2010, 64 (11): 1496-1502. 10.1111/j.1742-1241.2010.02484.x.
The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/14/204/prepub
The named authors submit this publication on behalf of the diamond study investigators which include: Prof Jane Gunn, Prof Helen Herrman, Prof Mike Kyrios, A/Prof Kelsey Hegarty, Prof Christopher Dowrick, Dr Gail Gilchrist, A/Prof Grant Blashki, Prof Dimity Pond, Dr Patty Chondros, A/Prof Renata Kokanovic and Dr Victoria Palmer. The diamond study was initiated with pilot funding from the beyondblue Victorian Centre of Excellence and the main cohort has received project grant funding from the National Health and Medical Research Council (ID 299869, 454463, 566511 & 1002908). The one year Computer Assisted Telephone Interview was funded by a Stream 3 grant from the Australian Primary Health Care Research Institute (APHCRI). No funding body had a role in study design; the collection, analysis, and interpretation of data; the writing of the manuscript; or the decision to submit this manuscript for publication. We acknowledge the 30 dedicated GPs, their patients and practice staff for making this research possible. We thank the cohort participants for their ongoing involvement in the study. We also thank the diamond project team and associate investigators involved in the study: A/Prof Lena Sanci, A/Prof Catherine Mihalopoulos, Ms Maria Potiriadis, Ms Konstancja Densley, Ms Aves Middleton, Dr Sandra Davidson and the casual research staff.
Assoc Prof Marie Pirotta is supported by a NHMRC (National Health and Medical Research Council) Career Development Fellowship.
Thanks to Mary Kyriakides for assistance in preparing this manuscript.
Funding: beyondblue Victorian Centre of Excellence; National Health and Medical Research Council (ID 299869, 454463 & 566511); Australian Primary Health Care Research Institute.
Ethics approval: University of Melbourne’s Human Research Ethics Committee, HREC 030613.
The authors declare that they have no competing interests.
MP contributed to the conception and design of the study, interpretation of the data, drafted the article and revised it for important intellectual content. KD performed the analysis and contributed to the interpretation of the diamond data and revised the manuscript for important intellectual content. KF contributed to interpretation of data, and revising the manuscript for important intellectual content. MC contributed to interpretation of data, and revising the manuscript for important intellectual content. JG contributed to the conception of the study and provided access and contributed to interpretation of the diamond data and revised the manuscript for important intellectual content. All authors read and approved the final version of the manuscript.
About this article
Cite this article
Pirotta, M., Densley, K., Forsdike, K. et al. St John’s wort use in Australian general practice patients with depressive symptoms: their characteristics and use of other health services. BMC Complement Altern Med 14, 204 (2014) doi:10.1186/1472-6882-14-204
- St John’s wort
- Hypericum perforatum
- General practice
- Complementary therapies
- Patient care